Table 1. Clinical and molecular... | American Society of Hematology

Table 1.

Clinical and molecular characteristics of t(17;19)⁺ ALL

Patient	Identification	Cell line	Age, y/sex	E2A-HLF type	Coagulopathy	Hypercalcemia	Outcome, mo^*	Reference
1	—	UOC-B1	15/F	1	+	+	23	1,6
2	—	—	15/F	1	+	+	NA	1
3	—	HAL-O1	17/F	1 (variant)	+	−	2.5	2
4	DEN-R	—	NA	2	−	NA	NA	4
5	RFH-N	—	NA	2	−	NA	NA	4
6	Pt1	—	17/F	2	−	−	56	7
7	Pt2	—	11/M	2	−	+	8.5	7
8	Pt3	—	13/M	1 + 2	−	+	NA	7
9	—	YCUB-2	4/M	2	−	+	NA	8
10	—	—	12/F	1	+	NA	8	9
11	—	Endo-kun	14/F	2	−	+	9	This paper
12	—	—	12/F	2	+	+	NA	This paper

Patient	Identification	Cell line	Age, y/sex	E2A-HLF type	Coagulopathy	Hypercalcemia	Outcome, mo^*	Reference
1	—	UOC-B1	15/F	1	+	+	23	1,6
2	—	—	15/F	1	+	+	NA	1
3	—	HAL-O1	17/F	1 (variant)	+	−	2.5	2
4	DEN-R	—	NA	2	−	NA	NA	4
5	RFH-N	—	NA	2	−	NA	NA	4
6	Pt1	—	17/F	2	−	−	56	7
7	Pt2	—	11/M	2	−	+	8.5	7
8	Pt3	—	13/M	1 + 2	−	+	NA	7
9	—	YCUB-2	4/M	2	−	+	NA	8
10	—	—	12/F	1	+	NA	8	9
11	—	Endo-kun	14/F	2	−	+	9	This paper
12	—	—	12/F	2	+	+	NA	This paper

Pt indicates patient; —, not available; and NA, not applicable.

All 12 patients died.